|
000
| 02661nam 2200373zi 4500 |
|---|
| 001 | 9.910940 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20231024135830 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 220505t20212021onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNM34-13/2021E-PDF |
|---|
| 100 | 1 |aFawcett, Jennifer, |eauthor. |
|---|
| 245 | 10|aReport : an overview of the COVID-19 vaccine rollout in Canada : |bcurating under quarantine / |cJennifer Fawcett. |
|---|
| 246 | 10|aOverview of the COVID-19 vaccine rollout in Canada : |bcurating under quarantine |
|---|
| 246 | 10|aCurating under quarantine |
|---|
| 264 | 1|aOttawa, Canada : |bIngenium, |c2021. |
|---|
| 264 | 4|c©2021 |
|---|
| 300 | |a1 online resource (vi, 11 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |a"May 2021." |
|---|
| 504 | |aIncludes bibliographical references (pages 10-11). |
|---|
| 520 | |a"The first half of 2020 saw the Canadian federal and provincial governments marshalling resources to mitigate the spread of COVID-19 through procurement of Personal Protective Equipment (PPE), and the development of protocols such as mask wearing and hand sanitization. The second half of the year saw a new focus on the procurement of vaccines and preparation for their rollout. From the start, the focus of the Canadian government has been to provide every eligible Canadian, who wishes to be vaccinated, a free vaccination by the end of 2021. The scope of this challenge has been extraordinary, given Canada's lack of domestic vaccine manufacturing infrastructure, the vast size of the country, and the diverse communities and cultural groups of our population - who all have different needs. Practically speaking, the vaccines themselves have come with their own manufacturing, storage and transportation issues. This environmental background report offers insight into the demands of this situation, highlighting the broad areas of responsibility at the federal, provincial, and territorial levels. Finally, there will be a short discussion on the need for accurate vaccine information campaigns in order to combat vaccine hesitancy within the population, and to dispel vaccine misinformation"--Context, page 1. |
|---|
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
|---|
| 650 | 0|aVaccines|zCanada. |
|---|
| 650 | 6|aCOVID-19|xVaccination|zCanada. |
|---|
| 650 | 6|aVaccins|zCanada. |
|---|
| 710 | 2 |aIngenium (Canada), |eissuing body. |
|---|
| 856 | 40|qPDF|s2.02 MB|uhttps://publications.gc.ca/collections/collection_2022/mstc-cstm/NM34-13-2021-eng.pdf |
|---|